Michael Earleywine

Michael Earleywine is a researcher working at the intersection of psychometrics, clinical outcomes and psychedelic-assisted interventions. His recent work emphasises the measurement and structural analysis of subjective psychedelic experiences (including network- and scale-based examinations of the Revised Mystical Experiences Questionnaire) and the empirical evaluation of therapeutic processes associated with psychedelic use.

Earleywine's published and in-progress studies address acute reactions to psychedelics and their association with post-acute changes in dysfunctional attitudes and wellbeing, comparative credibility and acceptability of psilocybin-assisted therapy versus cognitive behavioural therapy for depression, and clinician-reported themes around integration practices in psychedelic-assisted treatments. He has also investigated the role of emotional breakthrough and challenging experiences in psychedelic-facilitated improvements after bereavement. Across these projects he combines psychometric rigour with a clinical focus on mechanisms, safety, and pragmatic implications for therapeutic delivery.